Rheumatoid-arthritis drug Remicade price to be slashed

Published: 2011-12-02 07:00:00

Updated: 2011-12-02 07:00:00

Janssen Korea said yesterday that its rheumatoid-arthritis medication Remicade 100 mg (infliximab) will be reduced by 3.9 percent to 557,332 won per bottle from Dec. 1 as the Ministry of Health and Welfare has decided to expand the coverage of the medication fee through the national health insura...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK